NTRK1 Fusion in Glioblastoma Multiforme [PDF]
Glioblastoma multiforme (GBM) is the most aggressive form of brain tumor, yet with no targeted therapy with substantial survival benefit. Recent studies on solid tumors showed that fusion genes often play driver roles and are promising targets for ...
Jinkuk Kim +2 more
exaly +5 more sources
Novel NOTCH2-NTRK1 fusion confers osimertinib resistance in EGFR-mutant non-small cell lung cancer by interacting with EGFR [PDF]
Background: Overcoming osimertinib resistance in epidermal growth factor receptor (EGFR) mutant non-small cell lung cancer (NSCLC) is challenging due to unclear mechanisms. We previously reported a NSCLC case with EGFR mutations progressed on osimertinib
Hui Li +11 more
doaj +2 more sources
Case Report: Novel findings of larotrectinib in children with NTRK-rearranged spindle cell tumor [PDF]
Neurotrophic tropomyosin receptor kinase (NTRK)-rearranged spindle cell tumors are often resistant to chemotherapy and radiotherapy. Fortunately, they are sensitive to targeted therapy of tropomyosin receptor kinase (TRK) inhibitors. However, the data on
Linnan Wu +11 more
doaj +2 more sources
Fusion-Negative NTRK Overexpression Exhibit Biological Relevance in Colorectal Cancer: Implications for Prediction of Responses to Kinase Inhibitors [PDF]
Background/Objectives: The aims of this study are to define the roles of the neurotrophic tyrosine receptor kinase genes NTRK1, NTRK2 and NTRK3 (NTRK1/2/3) in CRC and to determine the clinicopathological, molecular, cancer signalling and potential ...
Abdulaziz Alfahed
doaj +2 more sources
Unidirectional Crosstalk Between NTRK1 and IGF2 Drives ER Stress in Chronic Pain [PDF]
Background: Chronic postsurgical pain (CPSP) poses a major clinical challenge due to unresolved links between neurotrophic pathways and endoplasmic reticulum (ER) stress.
Caixia Zhang +7 more
doaj +2 more sources
LMNA-NTRK1-rearranged spindle cell neoplasm with multiple relapses: a case report and literature review [PDF]
Neurotrophic tyrosine receptor kinase (NTRK)-rearranged spindle cell neoplasms (NTRK-RSCNs) constitute a rare, heterogeneous subset of soft tissue tumors defined by oncogenic fusions involving NTRK1, NTRK2, or NTRK3 genes. Despite the remarkable efficacy
Yinan Zhu +5 more
doaj +2 more sources
NTRK1-rearranged histiocytosis: clinicopathologic and molecular features. [PDF]
Abstract Non-Langerhans cell histiocytoses are a diverse group of histiocytic diseases. Different entities are defined based on clinical, histopathologic, and/or molecular characteristics. This study aimed to define NTRK-rearranged histiocytosis.
Fragneau R +34 more
europepmc +4 more sources
Rearrangements of NTRK1 gene in papillary thyroid carcinoma [PDF]
TRK oncogenes are observed in a consistent fraction of papillary thyroid carcinoma (PTC); they arise from the fusion of the 3' terminal sequences of the NTRK1/NGF receptor gene with 5' terminal sequences of various activating genes, such as TPM3, TPR and TFG.
Angela Greco
exaly +3 more sources
NTRK-rearranged spindle cell neoplasm of the female genital tract: case report and literature review [PDF]
NTRK-rearranged spindle cell neoplasm is a rare subtype of soft tissue sarcoma that occasionally arises in the lower female genital tract. Accurate diagnosis is clinically important, as these tumors generally display low-grade malignant behavior and may ...
Lulu Feng +7 more
doaj +2 more sources
Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer [PDF]
We identified new gene fusions in patients with lung cancer harboring the kinase domain of the NTRK1 gene that encodes the high-affinity nerve growth factor receptor (TRKA protein). Both the MPRIP-NTRK1 and CD74-NTRK1 fusions lead to constitutive TRKA kinase activity and are oncogenic. Treatment of cells expressing NTRK1 fusions with inhibitors of TRKA
Aria Vaishnavi +2 more
exaly +3 more sources

